Nucleic acid therapies: Towards cardiac-specific recombinant adeno-associated viruses (rAAVs) of human origin: Directed evolution and characterization of novel AAV variants isolated from human failing hearts in models with human relevance and relevance fo


Förderkennzeichen

81X2710183

Projektnummer

1315

Institution
Universitätsklinikum Hamburg-Eppendorf (UKE)
Projektleiter
Arne Hansen
Standort
Hamburg/Kiel/Lübeck
Projektart
Innovation Cluster
Fördersumme
€ 206.542,00
Beginn
01.01.2021
Ende
31.12.2024
Partnerprojekte